Jim Cramer Defended American Superiority and Discussed These 13 Stocks
In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer highlighted the often-overlooked role of currency fluctuations and explained why a weaker U.S.
Abbott Laboratories (ABT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lee Munder Capital Group Lee Munder | 148,737 | $19,729,963 | -8% | 1.31% |
| 2. | Ayrshire Capital Management John Nevin Jr. | 44,167 | $5,858,773 | -3% | 2.84% |
| 3. | Beech Hill Partners Paul Cantor, Joseph Weiss, And Will Wurm | 11,300 | $1,498,945 | -1% | 0.6% |
| 4. | Solstein Capital Nadine Terman And Jc Torres | 163 | $21,622 | 0.01% | |
| 5. | Sivik Global Healthcare Krishen Sud | 45,000 | $5,969 | -10% | 3.23% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $122.50 | 2,040 | 7,296 | 2021-02-23 | Filing | ||
| $73.40 | 2,000 | Officer | 52,562 | 2019-04-22 | Filing | |
| $72.32 | 100 | Director | 6,400 | 2019-01-31 | Filing | |
| $72.31 | 100 | Director | 6,300 | 2019-01-31 | Filing | |
| $72.33 | 1,800 | Director | 6,200 | 2019-01-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $136.65 | 200 | 71,928 | 2025-03-07 | Filing | ||
| $133.82 | 91,167 | 71,928 | 2025-03-06 | Filing | ||
| $138.17 | 949 | 74,381 | 2025-03-03 | Filing | ||
| $138.17 | 562 | 31,970 | 2025-03-03 | Filing | ||
| $138.17 | 1,111 | 66,878 | 2025-03-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,146,922 | $417,440,660 | 0.39% | |
| 2. | 1,875,990 | $248,850,074 | 0.42% | |
| 3. | 1,280,278 | $169,828,877 | 0.65% | |
| 4. | 1,074,844 | $142,578,070 | 0.27% | |
| 5. | 999,886 | $132,634,930 | 1.28% |
News See All
Abbott Laboratories (NYSE:ABT) Q1 2025 Earnings Call Transcript
Operator: Good morning, and thank you for standing by. Welcome to Abbott Laboratories' First Quarter 2025 Earnings Conference Call.
10 Innovative Healthcare Stocks to Watch in 2025
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased 7.5% from 2022 to $4.9 trillion in 2023.
10 Best Dividend Monarchs to Invest in Now
Dividend-focused investors are generally well-acquainted with terms like Dividend Aristocrats and Dividend Kings, but many may not be aware of a lesser-known group called Dividend Monarchs.
Jim Cramer’s Game Plan: 15 Stocks to Watch
He noted the chaotic nature of the current environment and remarked that "this tape has it all," and emphasized how unpredictable developments from the White House have added to the turbulence.
8 Most Profitable Dividend Stocks To Buy Now
When it comes to profits, dividend investing is the first thing that springs to mind.
12 Best Dividend Kings to Buy For Safe Dividend Growth
The importance of dividend stocks cannot be denied, even in today’s market environment, which is dominated by AI stocks.
10 Best S&P 500 Stocks to Buy For Dividend Growth
Dividend stocks have been attracting increasing interest lately, particularly following the tech sector’s sharp decline in March.
Diamond Hill Capital Stock Portfolio: Top 10 Stock Picks
Heather Brilliant, CFA, serves as CEO for Diamond Hill Capital and joined the firm in 2019, bringing over 20 years of domestic and international investment industry experience to this role.
15 Dividend Zombies to Invest in
The broader market has posted consecutive annual gains of 25%, largely fueled by growth stocks and companies capitalizing on the rising demand for artificial intelligence.
Billionaire Hedge Funds
